Walleye Capital
NVAX icon

Walleye Capital’s Novavax NVAX Stock Holding History

Walleye Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$449K Buy
41,499
+24,920
+150% +$223K ﹤0.01% 4187
2026
Q2 		$156K Sell
16,579
-21,341
-56% -$191K ﹤0.01% 3643
2026
Q1 		$309K Sell
37,920
-51,639
-58% -$468K ﹤0.01% 3045
2025
Q4 		$602K Buy
89,559
+76,525
+587% +$577K ﹤0.01% 2837
2025
Q3 		$113K Sell
13,034
-31,159
-71% -$243K ﹤0.01% 3655
2025
Q2 		$278K Buy
44,193
+25,790
+140% +$171K ﹤0.01% 3103
2025
Q1 		$118K Sell
18,403
-12,307
-40% -$102K ﹤0.01% 3549
2024
Q4 		$247K Sell
30,710
-29,259
-49% -$282K ﹤0.01% 3594
2024
Q3 		$757K Sell
59,969
-333,948
-85% -$4.31M ﹤0.01% 2928
2024
Q2 		$4.99M Buy
393,917
+392,035
+20,831% +$3.94M 0.01% 1291
2024
Q1 		$9K Buy
+1,882
New +$8.73K ﹤0.01% 5081
2023
Q3 		– Sell
-56,283
Closed -$418K – 5185
2023
Q2 		$418K Buy
+56,283
New +$443K ﹤0.01% 2562
2023
Q1 		– Sell
-109,536
Closed -$1.01M – 4236
2022
Q4 		$1.13M Buy
109,536
+34,335
+46% +$606K 0.02% 924
2022
Q3 		$1.37M Buy
+75,201
New +$3.26M 0.03% 762
2022
Q2 		– Sell
-10,273
Closed -$757K – 2612
2022
Q1 		$757K Buy
+10,273
New +$916K 0.02% 773

Other funds holding NVAX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Walleye Capital's NVAX Position: Q3 2026 in Review

Walleye Capital increased its Novavax (NVAX) stake by 150% in Q3 2026, buying an estimated $223K and bringing the position to 41,499 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #4187.

Walleye Capital first reported a position in NVAX in Q1 2022 and has held it in 15 quarters since. The position peaked at $4.99M in Q2 2024. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Walleye Capital held 41,499 shares of Novavax worth $449K as of Q3 2026.
  • Walleye Capital bought 24,920 Novavax shares in Q3 2026, an estimated $223K.
  • Novavax made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4187 holding.
  • Walleye Capital first reported a position in Novavax in Q1 2022 and has held it in 15 quarters since.
  • Walleye Capital's Novavax position peaked at $4.99M in Q2 2024.
  • 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.